Between 20,000 and 40,000 lung cancers are diagnosed each year in the United States in people who have never smoked or smoked fewer than 100 cigarettes in their lifetime. That accounts for 10% to 20% of all lung cancer cases. If lung cancer in non-smokers were classified as its own disease, it would still rank among the top ten cancer killers in the country.
The causes range from invisible gases seeping into your home to genetic mutations that arise without any known trigger. Understanding them matters, because many are preventable or at least detectable early.
Radon: The Leading Environmental Cause
Radon is a naturally occurring radioactive gas that forms when uranium in soil and rock breaks down. It seeps through cracks in foundations, gaps around pipes, and other openings, accumulating indoors where ventilation is poor. You can’t see, smell, or taste it. The EPA estimates radon causes about 21,000 lung cancer deaths per year in the U.S., and roughly 2,900 of those deaths occur in people who have never smoked.
When you breathe in radon, its radioactive particles settle in the lining of your lungs. Over years, this radiation damages the DNA in lung cells, which can eventually lead to cancer. The EPA recommends taking action to reduce radon levels when your home tests at or above 4 pCi/L (picocuries per liter), and suggests considering remediation even between 2 and 4 pCi/L. Testing is simple and inexpensive: hardware stores sell short-term test kits for under $20, and professional long-term testing is also widely available. If levels are high, a mitigation system (essentially a vent pipe with a fan) can reduce radon by up to 99%.
Secondhand Smoke
Living or working with someone who smokes increases your lung cancer risk by 20% to 30%, even if you’ve never touched a cigarette yourself. The smoke that drifts from the burning end of a cigarette actually contains higher concentrations of certain carcinogens than the smoke the smoker inhales through the filter. Years of regular exposure, particularly in enclosed spaces like homes or cars, compounds the damage. There is no safe level of secondhand smoke exposure.
Workplace Carcinogens
Several substances encountered in industrial and construction jobs are established lung carcinogens. Asbestos is the most well-known: microscopic fibers lodge deep in lung tissue and cause chronic inflammation that can lead to cancer decades after exposure. Chromium compounds (used in metal plating, stainless steel production, and leather tanning), arsenic (found in some pesticides and smelting operations), and diesel exhaust are also linked to lung cancer in non-smokers. The risk increases with the duration and intensity of exposure, and these carcinogens can interact with each other or with radon to multiply the danger.
Air Pollution and Indoor Fumes
Outdoor air pollution, particularly fine particulate matter from vehicle exhaust, industrial emissions, and wildfire smoke, is classified as a known human carcinogen. People living near busy roads or in cities with poor air quality face a measurably higher risk. Indoor sources matter too: cooking with solid fuels like coal or wood in poorly ventilated kitchens, common in many parts of the world, exposes the lungs to a concentrated mix of carcinogens over years. This is one reason lung cancer rates in non-smoking women are disproportionately high in certain regions of Asia.
Genetic Mutations That Drive the Disease
Lung cancer in non-smokers is biologically distinct from the type that develops in smokers. When researchers have profiled tumors from people who never smoked, they found targetable genetic mutations in 73% of cases. The most common is a mutation in the EGFR gene, present in about 51% of never-smoker lung cancers. Rearrangements in the ALK gene account for another 8%, and ROS1 fusions appear in roughly 2%.
These mutations cause cells to grow and divide uncontrollably. Some arise spontaneously as random copying errors when cells divide, not because of any specific exposure. Others may be triggered by environmental factors like radon or pollution, but the link isn’t always clear. The important practical implication is that these mutations make tumors responsive to targeted therapies, which are drugs designed to block the specific protein the mutation produces. This is a major reason why non-smokers with lung cancer tend to have more treatment options than they might expect.
Why Women Are Disproportionately Affected
Lung cancer in non-smokers is not evenly split between men and women. Research from Stanford found that the incidence rate in female never-smokers ranged from 14.4 to 20.8 cases per 100,000 person-years, compared to 4.8 to 13.7 in men. Extrapolated to the U.S. population, close to 20% of lung cancer cases in women occur in never-smokers, versus about 8% in men.
The reasons are not fully understood. One contributing factor is secondhand smoke: because men smoke at higher rates than women, women are more likely to be regularly exposed to a partner’s or coworker’s smoke even when they themselves never light up. Hormonal factors, differences in how women’s lung cells metabolize carcinogens, and varying patterns of occupational and indoor cooking exposures have all been proposed as partial explanations, but none has been conclusively proven as the primary driver.
Family History and Personal Health
Having a first-degree relative (parent, sibling, or child) with lung cancer increases your own risk, regardless of smoking status. Some of this is genetic, involving inherited variations in genes that repair DNA damage or suppress tumor growth. Some of it is shared environment: family members often live in the same radon-exposed home or breathe the same polluted air.
Certain pre-existing lung conditions also raise risk. Chronic inflammation from diseases like pulmonary fibrosis or long-standing infections like tuberculosis creates an environment where damaged cells are more likely to develop cancerous mutations over time.
How Non-Smoker Lung Cancer Differs
The most common type of lung cancer in non-smokers is adenocarcinoma, which typically develops in the outer regions of the lungs rather than near the central airways. This location matters because it means symptoms like cough and shortness of breath may not appear until the tumor is relatively large or has spread. About 60% of lung cancer patients, regardless of smoking history, are diagnosed at stage III or IV.
The good news is that survival outcomes are significantly better for non-smokers compared to smokers diagnosed at the same stage. Non-smokers tend to be younger at diagnosis, have fewer other health conditions, and are more likely to carry the genetic mutations that respond well to targeted drugs. One notable exception: non-smokers with a history of diabetes face a substantially worse prognosis, with more than three times the risk of dying from their cancer compared to non-smokers without diabetes.
Reducing Your Risk
You can’t eliminate every risk factor, but the most impactful step is testing your home for radon and fixing it if levels are elevated. Beyond that, minimizing exposure to secondhand smoke, ensuring good ventilation when cooking (especially with gas stoves), and wearing appropriate respiratory protection in industrial workplaces all meaningfully lower your risk. If you have a strong family history of lung cancer, talk to your doctor about whether low-dose CT screening makes sense for you, even as a non-smoker. Current screening guidelines are primarily designed for people with a smoking history, but the criteria are evolving as awareness of non-smoker lung cancer grows.